Recombinant VEGFR2 (Vulinacimab Biosimilar) antibody

Catalog No. ABIN7676122

This Human Monoclonal antibody specifically detects VEGFR2 (Vulinacimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant VEGFR2 (Vulinacimab Biosimilar) antibody (ABIN7676122)

Target: VEGFR2 (Vulinacimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-VEGFR2 (Vulinacimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab)

Characteristics: Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for VEGFR2 (Vulinacimab Biosimilar)

Target: VEGFR2 (Vulinacimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P35968